Apoptosis, cross-presentation, and the fate of the antigen specific immune response

Apoptosis

Volumn 5, Issue 4, 2000, Pages 307-314

  Bellone, M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Apoptosis; Cancer; Cross priming; Cross tolerance; Dendritic cells; T lymphocytes

Indexed keywords

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL DEATH; CELL INTERACTION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; APOPTOSIS; DENDRITIC CELLS; HUMANS; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; PHAGOCYTOSIS; SELF TOLERANCE; T-LYMPHOCYTES;

EID: 0033755720     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009671105696     Document Type: Article

References (92)

1. Apoptosis, a basic biological phenomenon with wide-ranging application in tissue kinetics
2. Cell death: The significance of apoptosis
3. Apoptosis. Phagocytic docking without shoking
4. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes
5. Apoptosis, the importance of being eaten
6. Apoptosis
7. Towards an understanding of the mocular mechanisms of physiological cell death
8. Activation-induced apoptosis in lymphocytes
9. Apoptosis and programmed ceil death in immunity
10. Phagocyte recognition of cells undergoing apoptosis
11. The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 intergin and requires intracellular and extracellular calcium
12. Dendritic cells acquire antigen form apoptotic cells and induce class I-restricted CTLs
13. Cutting edge: Bystander apoptosis triggers dendritic ceil maturation and antigen-presenting function
14. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
15. Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response
16. Salmonella-induced apoptosis of infected macrophages results in presentation of bacteria-encoded antigen after uptake by bystander dendritic cells
17. Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response
18. The induction of tolerance by dendritic cells that have captured apototic cells
19. The biochemistry and cell biology of antigen processing and presentation
20. Processing and presentation of endocytically acquired protein antigens by MHC class II and I molecules
21. MHC class I-restricted CTL responses to exogenous antigens
22. Cross-priming for secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in cytotoxicity assay
23. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxicity T cell level during in vivo priming
24. Antigen presentation to cytotoxic T lymphocytes in vivo
25. Cross-tolerance: A pathway for inducing tolerance to peripheral tissue antigens
26. Cytotoxic T lymphocyte activation by cross-priming
27. Autoantigens as substrates for apoptotic proteases: Implications for the phatogenesis of systemic autoimmune disease
28. Apoptosis in the effector phase of autoimmune diabetes, multiple sclerosis and thyroiditis
29. Autoimmune disease: Pathogenesis
30. Apoptosis in the rheumatic diseases
31. Lupus erythematosus in the 1980s: A survey of 570 patients
32. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens
33. Systemic exposure to irradiated apoptotic cells induces autoantibody production
34. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
35. Defect of a complement receptor 3 epitope in a patient with systemic lupus erythematosus
36. Complement-dependent clearance of apoptotic cells by human macrophages
37. The spontaneous apoptotic cell death of normal human lymphocytes in vitro: The release of, and immunoproliferative response to, nucleosomes in vitro
38. Enhancement of macrophage phagocytosis upon iC3b deposition on apoptotic cells
39. Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies
40. Apoptotic cell clearance in systemic lupus erythematosus. II. Role of β2 glycoprotein I
41. Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: Role of opsonizing anti-β2 glycoprotein I antibodies
42. The inability to process a self-peptide allows autoreactive T cells to escape tolerance
43. Suppressive effect of antibody on processing of T cell epitopes
44. Self-peptides in the initiation of lupus autoimmunity
45. How cryptic epitopes trigger autoimmunity
46. Modulation of antigen processing by bound antibody can boost or suppress class II MHC presentation of different T cell determinants
47. HIV-gp 120 activates autoreactive CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing
48. Cleavage by granzyme B is strongle predictive of autoantigen status: Implications for initiation of autoimmunity
49. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
50. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
51. Processing of engulfed apoptotic bodies yields T cell epitopes
52. + T cell responses to infectious agents, tumors, transplants and vaccines
53. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter
54. The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes
55. Immunosuppressive effects of apoptotic cells
56. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokines production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF
57. Dendritic cells and the control of immunity
58. Natural adjuvants: Endogenous activators of dendritic cells
59. Consequences of cell death: Exposure to necrotic tumor ceils, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
60. Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells
61. Mechanisms of alloimmunization and immunosuppression by blood transfusions in an inbred rodent model
62. Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen presenting cells, and cytokines
63. Role of antigen presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells
64. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction
65. Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines
66. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
67. Immunotherapy of tumors with autologous tumor-derived heath shock protein preparations
68. Apoptosis as a goal of cancer therapy
69. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance
70. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
71. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
72. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation
73. Dendritic cells progenitors phagocytose particulates, including Bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo
74. Selective transport of internalised antigens to the cytosol for MHC class I presentation in dendritic cells
75. Dendritic cells spill the beans
76. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli
77. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells
78. Developmental regulation of MHC class II trafficking in mouse dendritic cells
79. Processing of some antigens by the standard proteasome but not by the immuneproteasome results in poor presentation by dendritic cells
80. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes
81. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo
82. Tolerance, danger and the extended family
83. Does T-cell tolerance require a dedicated antigen-presenting cell?
84. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen
85. + T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen presenting cells
86. + T cells
87. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes
88. Role of tumor cell apoptosis in tumor antigen migration to draining lymph nodes
89. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population
90. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production
91. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs
92. The role of the ubiquitin-proteasome pathway in apoptosis